Bionano Genomics BNGO just pulled back the curtain on its fourth-quarter results, and the message is clear: the company is ...

Bionano Genomics, Inc. (NASDAQ:BNGO) Q4 2025 Earnings Call Transcript March 23, 2026 Bionano Genomics, Inc. reports earnings inline with expectations. Reported EPS is $-2.475 EPS, expectations were ...

Bionano Genomics, Inc. BNGO will release earnings results for its fourth quarter, after the closing bell on Monday, March 23.

Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the fourth quarter and full year ended December 31, 2025. "2025 demonstrated the momentum we built as a business,” commented ...

Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the fourth quarter and full year ended December 31, 2025. "2025 demonstrated the ...

Bionano Genomics Inc. stock grades by Barron's. View BNGO fundamental and sentiment analysis powered by MarketGrader.

Good day, and welcome to the Bionano Fourth Quarter and Full Year 2025 Earnings Conference Call. Today's conference is being recorded. At this time, I would like to turn the conference over to Webb ...

Bionano Genomics Inc (BNGO) reports improved gross margins and cost management amid revenue declines, with promising growth ...

Q4 2025 earnings call recap: 2026 revenue guidance, margin gains, CPT reimbursement catalyst, and consumables outlook—read now.

Bionano Genomics (NASDAQ: BNGO) participated in the 2026 American College of Medical Genetics and Genomics Annual Meeting (ACMG), held March 14–18 in Baltimore, Maryland. Twelve studies, representing ...